SILBER ALLAN C purchased 1.2% of their position (50K shares) of POINT BIOPHARMA GLOBAL INC. on the open market
Open‑market purchase worth $311.2K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/21/2022ACC: 0001104659-22-120873
Director
Since Jun 2021
+50K
Net shares
Net buyer
$311.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27.60K
Price / share
$6.00
Trade value
$165.62K
% of position
0.7%
11/17/2022
4.22M→4.25M
Common Stock
Direct
Shares
+22.40K
Price / share
$6.50
Trade value
$145.58K
% of position
0.5%
11/18/2022
4.25M→4.27M
Total
Net shares
+50K
Net value
$311.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2022 | P · Purchase | +27.60K | $6.00 | $165.62K | 0.7% | 4.22M | 4.25M |
| Common Stock Direct | 11/18/2022 | P · Purchase | +22.40K | $6.50 | $145.58K | 0.5% | 4.25M | 4.27M |
| Total | +50K | $311.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned313.88K
Common Stock
IndirectShares owned538.09K
Common Stock
IndirectShares owned71.74K
Common Stock
IndirectShares owned4.04M
Total
4.96M indirect4.96M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 313.88K | Indirect |
| Common Stock | 538.09K | Indirect |
| Common Stock | 71.74K | Indirect |
| Common Stock | 4.04M | Indirect |
| Total | 4.96M | 4.96M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported